Format

Send to:

Choose Destination
See comment in PubMed Commons below
Life Sci. 1997;61(2):75-94.

Neurotransmitter aberrations in schizophrenia: new perspectives and therapeutic implications.

Author information

  • 1Department of Pharmacology, University of Göteborg, Sweden.

Abstract

The dopamine hypothesis has dominated schizophrenia research for decades but is now yielding to a more diversified view, where the interaction of several neurotransmitters in complex circuitries is under scrutiny. Especially, glutamatergic and serotonergic mechanisms are attracting attention. However, the role of dopamine also needs further exploration and may still turn out to have novel therapeutic applications. In the present minireview an attempt is made to integrate preclinical and clinical data on neurotransmitter aberrations in schizophrenia and to discuss their therapeutic implications.

PMID:
9217267
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Write to the Help Desk